Ocuphire Announces APX3330 Phase 2 Data Presentations at Retina Meetings

Ocuphire Announces FDA Acceptance of New Drug Application and PDUFA Date of September 28, 2023 for Nyxol® Eye Drops for Reversal of Mydriasis

MicroCap Rodeo Winter Wonderland Best Ideas 2023 Conference

Feb 22, 2023 • 4:00pm EDT

Macula Society 46th Annual Meeting

Feb 15 – Feb 18, 2023